Ivermectin for COVID-19: Understanding the Dosage and FDA Approval

According to the latest medical consensus, the recommended dosage of Ivermectin for the treatment of COVID-19 is zero. This means that Ivermectin is not recommended for treating this viral infection by healthcare authorities. This article delves into the understanding of Ivermectin's role in the context of COVID-19 treatment, its recommended dosage, and whether it has FDA approval as a treatment for the disease.

Ivermectin: An Anti-Parasitic Drug, Not a COVID-19 Treatment

Ivermectin is an anti-parasitic drug primarily used to treat conditions such as scabies and strongyloidiasis. It is not effective against viral infections like COVID-19. This fact has been repeatedly emphasized by medical experts and health organizations worldwide.

Thorough clinical trials have concluded that Ivermectin is not an appropriate treatment for COVID-19. Several studies involving high doses of Ivermectin (600 or 1200 μg/kg) for 5 consecutive days in patients with early-stage mild symptoms have not shown any significant therapeutic effects. These trials were found to be implausible and their results inconclusive. Additionally, these studies were not designed as exclusive treatments for COVID-19 and have been criticized for their methodology.

FDA-Approved Usage of Ivermectin

Ivermectin is an FDA-approved anti-parasitic medication. The FDA has not approved it as a treatment for COVID-19. A significant finding from lab settings is that Ivermectin is an inhibitor of SARS-CoV-2 replication in a controlled environment. However, this does not translate to its effectiveness in humans. The transcription of its efficacy from laboratory settings to human treatment is scientifically challenging and unproven.

Medical Protocols and Recommendations

Current medical protocols recommend that for those with mild illness, over-the-counter symptomatic treatments such as cold medicines can be used. If breathing difficulties arise and SpO2 levels fall, immediate hospitalization is advised. The dosage of Ivermectin for non-COVID-19 related conditions is 0.3 mg per kilogram of body weight. For someone weighing 165 lbs (74 kg), the prescribed dosage would be 22.2 mg on day 1 and days 3, with a physician's clearance required.

Ivermectin does not cure COVID-19; rather, it is considered an adjunctive therapy. Therefore, it should only be used under medical supervision. Consultation with a medical doctor is essential before any treatment, and the use of Ivermectin should not be undertaken without expert guidance.

For those interested in further details on medical protocols, the Covid-Critical-Care website provides comprehensive information. It is crucial for individuals to follow the advice of healthcare professionals and adhere to guidelines set by health authorities to ensure safe and effective treatment.

In summary, Ivermectin is not an approved treatment for COVID-19. Its use for treating COVID-19 should be avoided as it is a viral infection, and Ivermectin is not effective in this context. Always seek professional medical advice for any health concerns and follow the guidelines set by health organizations.